Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PAIN THERAPEUTICS INC | 26,500 | reported | 23 May 2025 | tx 3+56,500 |
| Gain Therapeutics, Inc. | 15,000 | reported | 24 Jun 2025 | tx 4+51,000 |
| Chemomab Therapeutics Ltd. | 6,820 | reported | 16 Mar 2023 | tx 6+56,149 |
| Sarepta Therapeutics, Inc. | 0 | reported | 29 Jan 2026 | tx 27+107,440−29,517 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Jan 2026 | TAX_WITHHOLDING | Sarepta Therapeutics, Inc. | 6,780 | 21.23 USD | |
| 29 Jan 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 10,500 | 13.71 USD | |
| 29 Jan 2026 | EXERCISE | Sarepta Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 23 May 2025 | GRANT_AWARD | PAIN THERAPEUTICS INC | 26,500 | 0.00 USD | deriv |
| 12 Mar 2025 | SALE | Sarepta Therapeutics, Inc. | 2,491 | 99.64 USD | |
| 12 Mar 2025 | EXERCISE | Sarepta Therapeutics, Inc. | 9,746 | 25.18 USD | |
| 12 Mar 2025 | EXERCISE | Sarepta Therapeutics, Inc. | 9,746 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,383 | — | |
| 10 Mar 2025 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 4,792 | 0.00 USD | deriv |
| 24 Jun 2024 | GRANT_AWARD | Gain Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 09 May 2024 | GRANT_AWARD | PAIN THERAPEUTICS INC | 10,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 1,846 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,679 | 0.00 USD | deriv |
| 06 Dec 2023 | GRANT_AWARD | PAIN THERAPEUTICS INC | 20,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Gain Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,857 | 0.00 USD | deriv |
| 06 Mar 2023 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 1,523 | 0.00 USD | |
| 06 Mar 2023 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 3,257 | 0.00 USD | deriv |
| 20 Sept 2022 | GRANT_AWARD | Gain Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 19 Apr 2021 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 11,884 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Chemomab Therapeutics Ltd. | 6,820 | 0.00 USD | deriv |
| 07 Mar 2022 | GRANT_AWARD | Sarepta Therapeutics, Inc. | 2,953 | 0.00 USD |